Business
Block listing 6 Monthly Return
Shield Therapeutics plc has provided a six-monthly return for its share schemes, reporting a balance of 39,794 unallotted securities under the Retention Share Plan and 341,020 under the 2016 Company Share Option Plan, with no changes during the period from July 1, 2025, to December 31, 2025. The 2016 Long Term Incentive Plan also shows no activity, maintaining a balance of 24,273 unallotted securities. However, the Retention and Performance Share Plan saw an increase of 15,000,000 securities, with 6,137,791 issued, resulting in a closing balance of 11,733,071 unallotted securities. Disclaimer*
About this update from Shield Therapeutics Plc
[{"type":"text","content":"\n\n \nShield Therapeutics plc\n(\"Shield\" or the \"Company\" or the \"Group\")\n \nBlock Listing 6 Monthly Return\n \n\n\n\n\n Name of applicant:\n\n\nSHIELD THERAPEUTICS PLC\n \n\n\n\n\nName of scheme:\n\n\nShield Therapeutics Retention Share Plan\n\n\n\n\nPeriod of return:\n\n\nFrom:\n\n\n01 July 2025\n\n\nTo:\n\n\n31 December 2025\n\n\n\n\nBalance of unallotted securities under scheme(s) from previous return:\n\n\n39,794\n\n\n\n\nPlus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):\n\n\nNIL\n\n\n\n\nLess: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):\n\n\nNIL\n\n\n\n\nEquals: Balance under scheme(s) not yet issued/allotted at end of period:\n\n\n39,794\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n\nName of applicant:\n\n\nSHIELD THERAPEUTICS PLC\n \n\n\n\n\nName of scheme:\n\n\nShield Therapeutics plc 2016 Company Share Option Plan\n\n\n\n\nPeriod of return:\n\n\nFrom:\n\n\n01 July 2025\n\n\nTo:\n\n\n31 December 2025\n\n\n\n\nBalance of unallotted securities under scheme(s) from previous return:\n\n\n341,020\n\n\n\n\nPlus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):\n\n\nNIL\n\n\n\n\nLess: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):\n\n\nNIL\n\n\n\n\nEquals: Balance under scheme(s) not yet issued/allotted at end of period:\n\n\n341,020\n\n\n\n\n\n\n\n\n\n\n\n \n \n\n\n\n\n Name of applicant:\n\n\nSHIELD THERAPEUTICS PLC\n \n\n\n\n\nName of scheme:\n\n\nThe Shield Therapeutics plc 2016 Long Term Incentive Plan\n\n\n\n\nPeriod of return:\n\n\nFrom:\n\n\n01 July 2025\n\n\nTo:\n\n\n31 December 2025\n\n\n\n\nBalance of unallotted securities under scheme(s) from previous return:\n\n\n24,273\n\n\n\n\nPlus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):\n\n\nNIL\n\n\n\n\nLess: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):\n\n\nNIL\n\n\n\n\nEquals: Balance under scheme(s) not yet iss...